IL-1 RAcP

IL-1 RAcP 분자 정보

영어 이름Interleukin-1 receptor accessory protein시판 약물 수0
임상 약물 수8표적 별명Interleukin-1 receptor 3,IL-1RAcP,IL-1 receptor accessory protein,IL-1R-3,C3orf13,Interleukin 1 Receptor Accessory Protein,IL1R3,Interleukin-1 Receptor Accessory Protein Beta,IL-1R3
최고 연구 개발 단계Phase 2 Clinical
영어 이름Interleukin-1 receptor accessory protein
표적 별명Interleukin-1 receptor 3,IL-1RAcP,IL-1 receptor accessory protein,IL-1R-3,C3orf13,Interleukin 1 Receptor Accessory Protein,IL1R3,Interleukin-1 Receptor Accessory Protein Beta,IL-1R3
시판 약물 수0
임상 약물 수8
최고 연구 개발 단계Phase 2 Clinical

IL-1 RAcP 제품 목록

  • 속성

    Protein (11)Cell (1)

  • 제품 라이브러리

    온라인 (12)

  • Human (8)Mouse (1)Cynomolgus (1)Rat (1)Porcine (1)

  • 태그

    His Tag (8)Fc Tag (1)His Tag & Avi Tag (1)Fc Tag & Avi Tag (1)- (1)

  • 마커

    Unconjugated (7)Biotin-labeled (2)FITC Labeled (1)PE Labeled (1)- (1)

IL-1 RAcP분자 배경

Interleukin-1 receptor accessory protein (IL1RAP or IL-1RAcP) is also known as Interleukin-1 receptor 3 (IL-1R-3 or IL-1R3), C3orf13, which belongs to the interleukin-1 receptor family. IL1RAP contains three Ig-like C2-type (immunoglobulin-like) domains and one TIR domain. IL1RAP is detected in liver, skin, placenta, thymus and lung. IL-1R3 / IL1RAP is coreceptor with IL1R1, associates with IL1R1 bound to IL1B to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B and other pathways.

IL-1 RAcP분자 별명

IL1RAP,IL-1RAcP,C3orf13,IL1R3

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
NidanilimabCAN-04Phase 2 ClinicalLund University FoundationBiliary Tract Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Transitional Cell; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Melanoma; Myelodysplastic Syndromes; Pancreatic Neoplasms; Sarcoidosis, Pulmonary; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms
상세
CCTx-001CCTx-001Phase 2 ClinicalAdvesya SASLeukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
SAR-445399SAR-445399Phase 2 ClinicalSanofiHidradenitis Suppurativa; Immune System Diseases; Inflammation
상세
IBI-3011IBI-3011; IBI3011Phase 1 ClinicalArthritis, Gouty; Gout
상세
Gene modified anti-IL1RAP Chimeric Antigen Receptor T Cells therapy(Shanghai Zhongshan Hospital)Phase 1 ClinicalShanghai Zhongshan HospitalCarcinoma, Hepatocellular
상세
AK-135AK135; AK-135Phase 1 ClinicalPeripheral Nervous System Diseases
상세
DXP-106DXP-106; DXP106Phase 1 ClinicalSinglomics Biopharmaceuticals Co LtdNeoplasms; Solid tumours
상세
GSK-3903371GSK-3903371; BOS-371ClinicalGlaxosmithkline PlcNeoplasms
상세
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호